Cytotoxicity in human mucosal and cutaneous leishmaniasis
- 1 January 1995
- journal article
- Published by Wiley in Parasite Immunology
- Vol. 17 (1) , 21-28
- https://doi.org/10.1111/j.1365-3024.1995.tb00962.x
Abstract
CD8+ T cells and lysis of parasitized macrophages seem to be important in the resistance to murine leishmaniasis. In the present study, we evaluated peripheral blood mononuclear cell (PBMC) from patients with either cutaneous (CL) or mucosal (ML) leishmaniasis in cell lysis assays using 51-Cr-labeled Daudi or K562 cells, or autologous antigen-pulsed macrophages as targets. Results are reported as lytic units (number of cells required for 30% lysis) per million PBMC. Exposure of patient PBMC (n= 12) to lysate from Leishmania amazonensis promastigotes led to an increase in cytotoxic activity compared to unstimulated patient cells against Daudi (81.8 ± 14.9 vs 13.6 ± 5 lytic units (LU) per million PBMC; mean ± SEM) and K562 (65.7 ± 8.4 vs 13.1 ± 5 LU/106 PBMC). ML had higher responses than CL in both targets (80–4 ± 11.0 vs 46.4 ± 11.6 LU/106 PBMC for K562, and 104.3 ± 23.8 vs 59.3 ± 14.3 LU/106 PBMC for Daudi). Normal control PBMC, stimulated with L. amazonensis antigen had 6.32 ± 3.72 LU/106 PBMC against Daudi cells and 9.06 ± 2.78 LU/106 PBMC against K562. The cell responsible for lysis of the K562 cells was characterized as NK, by means of cell separation employing magnetic beads coupled to antibodies. Addition of recombinant TGF-β or recombinant human IL-10 reduced L. amazonensis-mdwcec? cytotoxicity by 90% and 70%, respectively. Cytotoxicity of antigen-stimulated PBMC was also demonstrated against autologous L. amazonensis antigen-pulsed macrophages in the range of 6.7 to 41.7LU/106 PBMC. In this system TGF-β and IL-10 also decreased the antigen-induced cytotoxic response.Keywords
This publication has 19 references indexed in Scilit:
- Interleukin 10 production correlates with pathology in human Leishmania donovani infections.Journal of Clinical Investigation, 1993
- Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reactionClinical and Experimental Immunology, 1993
- Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape MechanismScience, 1992
- The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages.The Journal of Experimental Medicine, 1991
- Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.The Journal of Experimental Medicine, 1989
- The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.The Journal of Experimental Medicine, 1989
- Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparumNature, 1988
- The relevance of characterizing Leishmania from cutaneous lesions: a simple approach for isolationMemórias do Instituto Oswaldo Cruz, 1987
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987
- Splenic natural killer-cell activity in mice infected with Leishmania donovaniCellular Immunology, 1984